In leukemia, the acute myeloid leukemia cells (AMLs) lack ASS1 expression, and deprivation of arginine by ADI-PEG20 reduces AML tumor burden in vivo and in vitro (45). This evidence concerns the gene ASS1 and acute myeloid leukemia.